290 related articles for article (PubMed ID: 29380244)
1. Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture.
Najar M; Fayyad-Kazan M; Meuleman N; Bron D; Fayyad-Kazan H; Lagneaux L
Mol Cell Biochem; 2018 Oct; 447(1-2):111-124. PubMed ID: 29380244
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects of foreskin mesenchymal stromal cells on natural killer cells.
Najar M; Fayyad-Kazan M; Meuleman N; Bron D; Fayyad-Kazan H; Lagneaux L
J Cell Physiol; 2018 Jul; 233(7):5243-5254. PubMed ID: 29194614
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation of endothelial differentiated mesenchymal stromal cells: impact on T and NK cells.
El Omar R; Xiong Y; Dostert G; Louis H; Gentils M; Menu P; Stoltz JF; Velot É; Decot V
Immunol Cell Biol; 2016 Apr; 94(4):342-56. PubMed ID: 26510892
[TBL] [Abstract][Full Text] [Related]
4. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
6. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
[TBL] [Abstract][Full Text] [Related]
7. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
[TBL] [Abstract][Full Text] [Related]
8. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.
Mrahleh MA; Matar S; Jafar H; Wehaibi S; Aslam N; Awidi A
Front Immunol; 2021; 12():732549. PubMed ID: 34650558
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
Shi Q; Gao J; Jiang Y; Sun B; Lu W; Su M; Xu Y; Yang X; Zhang Y
Stem Cell Res Ther; 2017 Nov; 8(1):246. PubMed ID: 29096715
[TBL] [Abstract][Full Text] [Related]
10. Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton's Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells.
Karaöz E; Çetinalp Demircan P; Erman G; Güngörürler E; Eker Sarıboyacı A
Turk J Haematol; 2017 Aug; 34(3):213-225. PubMed ID: 27610554
[TBL] [Abstract][Full Text] [Related]
11. The effect of transplanted human Wharton's jelly mesenchymal stem cells treated with IFN-γ on experimental autoimmune encephalomyelitis mice.
Torkaman M; Ghollasi M; Mohammadnia-Afrouzi M; Salimi A; Amari A
Cell Immunol; 2017 Jan; 311():1-12. PubMed ID: 27697286
[TBL] [Abstract][Full Text] [Related]
12. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.
Najar M; Fayyad-Kazan M; Meuleman N; Bron D; Fayyad-Kazan H; Lagneaux L
J Cell Commun Signal; 2018 Dec; 12(4):673-688. PubMed ID: 29350342
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive properties of Wharton's jelly-derived mesenchymal stromal cells in vitro.
He H; Nagamura-Inoue T; Takahashi A; Mori Y; Yamamoto Y; Shimazu T; Tsunoda H; Tojo A
Int J Hematol; 2015 Sep; 102(3):368-78. PubMed ID: 26228529
[TBL] [Abstract][Full Text] [Related]
15. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells.
Sharma T; Kumari P; Pincha N; Mutukula N; Saha S; Jana SS; Ta M
Cytotherapy; 2014 May; 16(5):640-52. PubMed ID: 24210786
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
Zhang J; Chen GH; Wang YW; Zhao J; Duan HF; Liao LM; Zhang XZ; Chen YD; Chen H
Chin Med J (Engl); 2012 Oct; 125(19):3472-8. PubMed ID: 23044308
[TBL] [Abstract][Full Text] [Related]
18. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
[TBL] [Abstract][Full Text] [Related]
19. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
[TBL] [Abstract][Full Text] [Related]
20. Activation of NK Cells in Mixed Cultures of Wharton's Jelly Mesenchymal Stromal Cells and Peripheral Blood Lymphocytes.
Svirshchevskaya EV; Poltavtsev AM; Os'mak GZ; Poltavtseva RA
Bull Exp Biol Med; 2018 Jan; 164(3):339-343. PubMed ID: 29313232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
